JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITEDJOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITEDJOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED

JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪27.83 B‬CNY
0.41CNY
‪2.17 B‬CNY
‪149.71 B‬CNY
‪1.73 B‬
Beta (1Y)
1.16
Employees (FY)
‪30.1 K‬
Change (1Y)
−41 −0.14%
Revenue / Employee (1Y)
‪700.54 K‬CNY
Net income / Employee (1Y)
‪10.17 K‬CNY

About JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED


CEO
Wei He
Website
Headquarters
Wuhan
Founded
1999
ISIN
CNE100000W45
FIGI
BBG0014WRV86
Jointown Pharmaceutical Group Co., Ltd. engages in the wholesale of drugs, medical devices and other products, retail chains, drug production and research and development, and related value-added services. It also operates pharmaceutical logistics centers, e-commerce, and retail chains. The company was founded by Bao Lin Liu and Shu Lin Liu on March 9, 1999 and is headquartered in Wuhan, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 600998 is 5.48 CNY — it has decreased by −0.72% in the past 24 hours. Watch JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED stocks are traded under the ticker 600998.
600998 stock has fallen by −3.86% compared to the previous week, the month change is a 6.20% rise, over the last year JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED has showed a −3.69% decrease.
We've gathered analysts' opinions on JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED future price: according to them, 600998 price has a max estimate of 8.60 CNY and a min estimate of 3.80 CNY. Watch 600998 chart and read a more detailed JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED stock forecast: see what analysts think of JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED and suggest that you do with its stocks.
600998 reached its all-time high on Jun 15, 2015 with the price of 13.08 CNY, and its all-time low was 3.11 CNY and was reached on Jan 6, 2012. View more price dynamics on 600998 chart.
See other stocks reaching their highest and lowest prices.
600998 stock is 2.97% volatile and has beta coefficient of 1.16. Track JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED stock price on the chart and check out the list of the most volatile stocks — is JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED there?
Today JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED has the market capitalization of ‪27.83 B‬, it has decreased by −0.18% over the last week.
Yes, you can track JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED financials in yearly and quarterly reports right on TradingView.
JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED is going to release the next earnings report on Apr 29, 2025. Keep track of upcoming events with our Earnings Calendar.
600998 earnings for the last quarter are 0.10 CNY per share, whereas the estimation was 0.10 CNY resulting in a 1.59% surprise. The estimated earnings for the next quarter are 0.15 CNY per share. See more details about JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED earnings.
JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED revenue for the last quarter amounts to ‪36.26 B‬ CNY, despite the estimated figure of ‪37.79 B‬ CNY. In the next quarter, revenue is expected to reach ‪37.73 B‬ CNY.
600998 net income for the last quarter is ‪488.55 M‬ CNY, while the quarter before that showed ‪669.96 M‬ CNY of net income which accounts for −27.08% change. Track more JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED financial stats to get the full picture.
Yes, 600998 dividends are paid annually. The last dividend per share was 0.25 CNY. As of today, Dividend Yield (TTM)% is 3.51%. Tracking JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED dividends might help you take more informed decisions.
JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED dividend yield was 3.57% in 2023, and payout ratio reached 44.94%. The year before the numbers were 2.57% and 30.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has ‪30.10 K‬ employees. See our rating of the largest employees — is JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED on this list?
Like other stocks, 600998 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED stock shows the sell signal. See more of JOINTOWN PHARMACEUTICAL GROUP COMPANY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.